OFFERED BY

Incorporates

Outsourcing Models Solutions

PAREXEL Biopharm Unit

Helping to simplify your drug development journey

Emerging biopharma companies like yours are the genesis of innovation for the biopharmaceutical industry. Recent data indicates that 80 percent of ongoing development programs originated outside the top 25 pharmaceutical companies. That’s why PAREXEL launched its BioPharm Unit in 2012 – to deliver innovative solutions to help small to mid-sized companies expand their in-house expertise, support internal decision-making and position themselves among industry leaders.

Companies that partner with the PAREXEL BioPharm Unit benefit from:

A senior PAREXEL executive who provides clear direc­tion and assures that our work links with your objectives

A flexible relationship model that allows you to access specific expertise, resources and technology when you need it most

Global drug development, scientific and regulatory expertise to help optimize protocols and trial design and navigate regulatory authorities for approval

Commercialization strategies to help accelerate development options, substantiate value and vet evidence with payer networks early and throughout development

Offices across Europe, Asia and the Americas that provide access to sites and patient populations around the world

Accountability for delivery, quality and alignment of incentives in meeting your clinical development milestones

Within this broad expertise, PAREXEL has extensive clinical trial experience in oncology and hematology; central nervous system disorders; cardiovascular, metabolic and infectious diseases; and many other therapeutic areas.

Designing the right model to accomplish your goals

At PAREXEL, we know that no two projects are ever the same. That’s why we work closely with every client to determine the very best model, and then tailor that model to meet the specific needs of each company. By creating a true sense of project ownership and collaboration, we act as your partners, where our success is only measured by yours.

From delivering smarter solutions to anticipating your specific needs, we truly believe the people you choose to work with make all the difference. When you choose PAREXEL, you not only get 100% dedication to every project, every time, you also get a partner who is focused on the most important thing of all – your success.

PAREXEL Creates Customized Biopharm Unit

Explore PAREXEL® BioPharm Unit

All Solutions

All Solutions

Clinical Research

Informatics

Consulting

View More...

Early Phase Services

More of What You Need for a Stronger Start in Phase I. Your journey from new molecule to new medicine starts with appropriate subjects, world class facilities, and more timely results. PAREXEL® provides comprehensive early phase testing services through our own hospital-based clinical units on three continents.

Phase II-III Services

Improving Your Journey by Improving Every Step of Your Clinical Trials.
During the part of your journey from Proof-of-Concept through regulatory submission, PAREXEL® Phase II-III specialists optimize every step of your clinical trials by every means possible.

Regulatory Compliance & Risk Management

Our trusted experts, including renowned former regulators, know how to institute proactive compliance and have a strong track record of helping companies get out of regulatory crises. They are well versed in biopharmaceutical, medical device / diagnostic regulations and ICH guidance, and are focused on the success of your products and company.

Integrated Product Development

Journeys, of course, have varied destinations. But whether you’re taking a new molecule to market, exploring how to differentiate a current product, or evaluating new geographic options, PAREXEL®’s Integrated Product Development team can shorten your product’s time to market and provide the strategic bandwidth and marketplace resources to help that product achieve more commercially.

Medical Communications

Successful commercialization is no longer just about gaining regulatory approval. It is about meeting the needs of a growing number of stakeholders, including physicians, patients, governments and payers. Success requires integrated pharmaceutical teamwork, including the right Medical Communications expertise where needed, to address the traditional silos of R&D, marketing and regulatory and focus on the same goals.